Skip to main content
Premium Trial:

Request an Annual Quote

German Firms Evotec, Definiens to Co-develop Cellular Assay-analysis Platform

NEW YORK, July 31 - German text-mining software provider Definiens and genomics-tool maker Evotec Technologies will co-develop an informatics-based platform for cellular-assay analysis and drug discovery.


To facilitate the collaboration, designed to enable researchers to perform high throughput screening of assays in cell biology, Evotec will ensure that its Libretto software will be compatible with Definiens Cellenger platform. According to Definiens, the Challenger software enables researchers to perform automated tissue and cellular-assay analysis.


Evotec's confocal  microplate analyzer for image detection, called Opera, will also be folded into the development project. "Cellenger further extends Opera's capabilities as an open platform for cell biology experimentation, and with our  open software architecture we could implement this extension quickly" said Evotec CSO Rolf G nther.


Added Uli Berresheim, CEO of  Definiens: "We are going to create a system that will automatically provide the user with valuable information about cells, cell components, and their mutual relations."


The companies expect to launch the platform by the end of September. Financial details of the deal were not disclosed.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.